The global ophthalmoscopes market is expected to reach US$ 322.13 Mn in 2027 from US$ 216.79 in 2018. The ophthalmoscopes market is estimated to grow with a CAGR of 4.6% from 2019-2027. The market is driven by the factors such as, rising prevalence of eye diseases in developing and developed nations, significantly growing elderly population and increasing prevalence of glaucoma in individuals are likely to drive the growth of the market in the forecasted period. However, the challenges associated with retinal examination may show some impact to the growth of the market. Increasing prevalence of glaucoma is likely to grow the ophthalmoscopes market significantly in the forecast period.Glaucoma is a very misunderstood diseases and people often neglect its severity.
Glaucoma is a disorder or a disease that damages the eye’s optic nerve.The condition occurs when a layer of fluid fills up on the outer side of the eye, creating a pressure and hence leading to damage to optic nerves.
Glaucoma often leads to vision loss, eventually causing blindness. As per the WHO it is stated that glaucoma is the second cause of the blindness in the world it estimates that 4.5 million people worldwide are blind due to glaucoma. In the United States, around 120,000 are blind from glaucoma, accounting for 9% to 12% of all cases of blindness. The geriatric population is the most susceptible to vision loss due to glaucoma However, if it is detected and treated at an early stage, one can avoid vision loss. The worldwide age-standardized prevalence of glaucoma in the population aged 40 years and above is estimated to be around 3.5%. Therefore, owing to the factor the market is likely to boost in the forecast period. Global ophthalmoscopes market was segmented by type, application and end user.The type segment was further divided as direct and indirect ophthalmoscopes.
The direct ophthalmoscopes segment was the largest market and is expected to dominate in the coming future, Based on the application, the market was led by the glaucoma and similarly, based on the end user the hospitals segment led the ophthalmoscopes market in the forecast period. Some of the major primary and secondary sources included in the report for the ophthalmoscopes market are World Health Organization, Dubai Health Authority, National Agency for Accreditation and Evaluation in Health, Korean Ophthalmological Society, National Health Interview Survey, Royal Society of Medicine, Centers For Disease Control And Prevention, Pan American Health Organization, International Diabetes Federation and others.
Reasons to Buy Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the ophthalmoscopes market.
Highlights key business priorities in order to assist companies to realign their business strategies.
The key findings and recommendations highlight crucial progressive industry trends in the global ophthalmoscopes market, thereby allowing players across the value chain to develop effective long-term strategies.
Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.
Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.
Our reports have been used by over 10K customers, including:
The global ophthalmic devices market is predicted to surpass US$ 67 Billion by 2026. Ophthalmic devices are medical devices used in the identification and treatment of ocular defects or deficiencies and eye disorders. The ophthalmic devices are designed for diagnostics, surgical, and vision correction purposes. These devices are continuously...
Soluble Guanylate Cyclase - Pipeline Review, H1 2020 Summary Soluble Guanylate Cyclase (sGC or EC 220.127.116.11) – Soluble guanylyl cyclase (sGC) is the known receptor for nitric oxide. Binding of nitric oxide to the heme moiety of the cyclase induces its capacity to synthesize the second messenger cGMP....
Age Related Macular Degeneration - Pipeline Review, H1 2020 Summary This latest Pharmaceutical and Healthcare disease pipeline guide Age Related Macular Degeneration - Pipeline Review, H1 2020, provides an overview of the Age Related Macular Degeneration (Ophthalmology) pipeline landscape. Age...
422 pages •
By The Business Research Company
• May 2020
Ophthalmology Drugs Global Market Opportunities And Strategies To 2030: COVID 19 Impact And Recovery report provides the strategists, marketers and senior management with the critical information they need to assess the global ophthalmology drugs market as it emerges from the COVID 19 shut down. Description: Where...
Growth in the target patient population and awareness programs for wound care treatment and management are expected to drive the overall growth of the amniotic products market. The global amniotic products market is projected to reach USD 1,095 million by 2025 from USD 748 million in 2020, at a CAGR of 7.9%. Market growth is largely driven...
Macular Edema - Pipeline Review, H1 2020 Summary This latest Pharmaceutical and Healthcare disease pipeline guide Macular Edema - Pipeline Review, H1 2020, provides an overview of the Macular Edema (Ophthalmology) pipeline landscape. Macular edema is swelling or fluid retention in a specialized...